Is bivamelagon available for purchase?

No. Bivamelagon (LB54640) is an investigational oral MC4R agonist developed by Rhythm Pharmaceuticals for hypothalamic obesity. It is in Phase 2 clinical trials and is not available through any pharmacy or peptide vendor. It targets a rare condition (hypothalamic obesity) and is unlikely to be widely accessible even after approval.

How does bivamelagon differ from melanotan-2 or PT-141?

While bivamelagon, melanotan-2, and PT-141 all interact with melanocortin receptors, bivamelagon is specifically designed as a selective oral MC4R agonist for hypothalamic obesity, while melanotan-2 is a non-selective melanocortin agonist and PT-141 (bremelanotide) is FDA-approved for hypoactive sexual desire disorder. They have different selectivity profiles, routes of administration, and clinical targets.

Could bivamelagon be used for weight loss in general obesity?

Bivamelagon is being developed specifically for hypothalamic obesity, a rare condition caused by hypothalamic damage. Its efficacy and safety in general obesity have not been studied. Previous MC4R agonists have shown cardiovascular side effects (increased heart rate, blood pressure) that may limit their use in broader obesity populations.

Bivamelagon: Community Protocols & Reports

Aggregated community experiences, protocols, and stacking patterns

Anecdotal Reports0

Community-Sourced Information

The protocols and reports on this page are gathered from online communities and forums. They represent anecdotal experiences, not clinical evidence. Individual results vary significantly. This information is not medical advice and should not replace consultation with a qualified healthcare provider. Always verify dosing and safety information with peer-reviewed research before making any decisions.

For peer-reviewed dosing protocols, see the clinical dosing guide.

Browse community protocols for all 130 peptides →

✓Reviewed byEditorial Team

📅Updated February 16, 2026

Unverified

📌TL;DR

•Community protocols detailed below
•Evidence level: Anecdotal Reports
•See community reports below
•Stacking patterns detailed below

Sources

Reddit r/Peptides|MC4R agonist pipeline and melanocortin receptor discussions(accessed 2026-02-16)
Reddit r/obesity|Hypothalamic obesity treatment discussions(accessed 2026-02-16)

Community Evidence Overview#

This page documents the community evidence landscape for bivamelagon (LB54640). This is not clinical evidence and should not be used as medical guidance.

Bivamelagon has no community self-experimenter data. It is an investigational small molecule MC4R agonist in Phase 2 clinical trials for a rare form of obesity.

Why There Is No Community Data#

Rare Disease Indication#

Bivamelagon is being developed specifically for hypothalamic obesity in patients aged 12 and older, a rare condition affecting a small patient population. This niche indication means it generates minimal community interest compared to broadly applicable weight loss medications.

Pre-Market Status#

As a Phase 2 investigational compound, bivamelagon is only available within clinical trial settings. It is a proprietary small molecule developed by Rhythm Pharmaceuticals (licensed from LG Chem) and has never been synthesized or sold by peptide vendors.

Melanocortin Receptor Context#

While the peptide community has extensive experience with melanocortin receptor agonists like melanotan-2 and PT-141, those compounds are non-selective agonists used for tanning and sexual function. Bivamelagon's selective MC4R agonism for appetite regulation represents a distinct pharmacological approach with different goals and risk profiles.

Bivamelagon Research & Clinical Studies
Bivamelagon Molecular Profile
Setmelanotide - Approved MC4R pathway agonist for genetic obesity
Melanotan-2 - Non-selective melanocortin agonist with community data

Subscribe to see vendor options

Free access to verified vendor scores, pricing, and suppliers.

150+ peptide profiles · 30+ comparisons · 18 research tools

Already subscribed?

Frequently Asked Questions About Bivamelagon

Explore Further

Calculate your dose

Reconstitution volumes, injection doses, and supply planning

⚠️

Medical Disclaimer

This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.

Compare Tools Vendors